Numerous liver diseases, such as viral hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, primary hepatocellular carcinoma, and hepatic ischemia–reperfusion damage, have been linked to the crucial function of cGAS-STING signaling [43]. Here, STING1 is linked to metabolic dysfunction-associated steatotic liver disease.